Venous thromboembolism is a relevant and underestimated adverse event in cancer patients treated in phase I studies

por Mandalà, M, Grosso, F, Vitalini, C, Corradino, I, Sanfilippo, R, Colombini, S, Clerici, M, Labianca, R, De Pascale, A, Marsoni, S
Publicado 2012

BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients

por Laroche-Clary, A, Chaire, V, Le Morvan, V, Neuville, A, Bertucci, F, Salas, S, Sanfilippo, R, Pourquier, P, Italiano, A
Publicado 2015